APA (7th ed.) Citation

A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, & G. A. Procenko. (2020). Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease. Столичная издательская компания.

Chicago Style (17th ed.) Citation

A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, and G. A. Procenko. Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease. Столичная издательская компания, 2020.

MLA (9th ed.) Citation

A. E. Nikitin, et al. Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease. Столичная издательская компания, 2020.